Care Oncology Clinic
Who should consider arthritis testing?
Arthritis testing is appropriate for individuals who experience persistent joint pain, swelling, stiffness or reduced range of motion. People with a family history of rheumatoid arthritis or other autoimmune diseases may want to assess their risk. Testing is also useful if you have unexplained fatigue, low-grade fever or difficulty performing everyday tasks, which can accompany inflammatory joint conditions. Early detection allows for earlier intervention, which may slow disease progression and improve quality of life.
Athletes, people with repetitive strain injuries or those recovering from joint injury may use testing to distinguish between mechanical joint problems and systemic inflammatory conditions. Monitoring markers of inflammation can inform treatment decisions and track the effectiveness of therapy.
Why test from home?
Home testing allows you to check markers of inflammation, such as C-reactive protein and rheumatoid factor, without visiting a clinic (although we support that option too). This convenience encourages earlier investigation of joint symptoms, which is crucial because delays in diagnosis can lead to joint damage. At-home testing provides privacy and reduces the anxiety associated with hospital visits, particularly for those who find mobility difficult due to pain.
Testing at home also enables regular monitoring to see how your markers respond to medications or lifestyle changes. By tracking trends, you and your healthcare provider can adjust treatment plans more effectively, potentially improving outcomes.
How it works
A blood test kit is delivered to your home with instructions and a finger-prick device. You collect a small blood sample and return it to the laboratory. The lab measures inflammatory markers and autoantibodies associated with rheumatoid arthritis and other inflammatory joint conditions. Results are presented in a report explaining each marker’s role and whether it is elevated. If results suggest an inflammatory condition, you should consult your GP or rheumatologist for further evaluation and treatment. Regular re‑testing can track disease activity and monitor how your body responds to therapy.
